title: No role for the CYP3A5*3 polymorphism in intestinal and hepatic metabolism of midazolam.
authors.forename: D
authors.initials: D
authors.lastname: Tomalik-Scharte
authors.forename: O
authors.initials: O
authors.lastname: Doroshyenko
authors.forename: J
authors.initials: J
authors.lastname: Kirchheiner
authors.forename: A
authors.initials: A
authors.lastname: Jetter
authors.forename: A
authors.initials: A
authors.lastname: Lazar
authors.forename: T
authors.initials: T
authors.lastname: Klaassen
authors.forename: D
authors.initials: D
authors.lastname: Frank
authors.forename: C
authors.initials: C
authors.lastname: Wyen
authors.forename: G
authors.initials: G
authors.lastname: Fätkenheuer
authors.forename: U
authors.initials: U
authors.lastname: Fuhr
mesh_terms: D000284:Administration, Oral; D000328:Adult; D001682:Biological Availability; D016022:Case-Control Studies; D051544:Cytochrome P-450 CYP3A / Q000235:genetics / Q000378:metabolism*; D005260:Female; D015658:HIV Infections / Q000097:blood; D006679:HIV Seropositivity / Q000097:blood; D006801:Humans; D007275:Injections, Intravenous; D007413:Intestinal Mucosa / Q000378:metabolism*; D008099:Liver / Q000378:metabolism*; D008297:Male; D008657:Metabolic Clearance Rate; D008874:Midazolam / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000493:pharmacokinetics; D008875:Middle Aged; D011110:Polymorphism, Genetic
chemical_list: C510164:CYP3A5 protein, human; D051544:Cytochrome P-450 CYP3A; D008874:Midazolam